Rheumatology Advance Access published online on May 30, 2003
Rheumatology, doi:10.1093/rheumatology/keg316
Rheumatology © British Society for Rheumatology 2003; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Papers
1 Academic Department of Pathophysiology (AIDS Unit), School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
* Corresponding author. E-mail: tkordoss{at}med.uoa.gr.
Received 14 September 2002
; accepted 12 February 2003
Objective. This study was performed in order to investigate the prevalence of Sjögren-like syndrome (SLS) in the highly active anti-retroviral therapy (HAART) era in a cohort of HIV-1-positive Greek patients. Methods. One hundred and thirty-one unselected patients were screened by the validated European Union (EU) criteria for Sjögren's syndrome. Of the 31 who gave a positive EU-validated questionnaire, 17 consented to undergo minor salivary gland biopsy and other tests. Results. Only two patients had a positive salivary gland biopsy and both belonged to the non-compliant HAART group, whereas none of the compliant HAART patients had histological findings. Conclusions. It is concluded that SLS, the prevalence of which in the pre-HAART era was 7.8%, has disappeared, possibly as a result of the protective action of HAART.
Key words: Sjögren-like syndrome, HIV infection, HAART, Pathology.
Paucity of Sjögren-like syndrome in a cohort of HIV-1-positive patients in the HAART era. Part II
2 Academic Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
3 Laboratory of Nuclear Medicine, Laikon General Hospital, Athens, Greece
4 Dental Clinic, Laikon General Hospital, Athens, Greece
5 Eye Clinic, Laikon General Hospital, Athens, Greece
6 Academic Departments of Pathophysiology (AIDS Unit), School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
![]()
CiteULike
Connotea
Del.icio.us What's this?